Home' Australian Pharmacist : Australian Pharmacist July 2015 Contents Australian Pharmacist July 2015 I © Pharmaceutical Society of Australia Ltd.
PHARMACY PRACTICE TRAINING
People with osteoarthritis aren’t managing their symptoms according
to guideline recommendations despite being unsatisfied with their pain
Osteoarthritis is the most common
arthritis type, and a leading cause
of disability. However, many
patients experiencing symptoms
Findings from the
Voltaren® Osteo Gel Keep Moving Report,
involving 515 Australians aged 55 years
and over with chronic joint pain related
to ageing revealed that almost half of
respondents waited three months before
seeking healthcare professional advice,
while one in ten waited several years.
By providing professional counselling
for patients with osteoarthritis,
the pharmacy profession has the
ideal opportunity to introduce a
professional service that will be valued
by the community. Pharmacists are
actively involved in the provision
of drug information, patient
education, and disease management,
with demonstrated improvement
in patient outcomes.
pharmacists are ideally placed to screen
for osteoarthritis because they are
often consulted about over-the-counter
analgesics for the management of
Once diagnosed, research shows
osteoarthritis may be suboptimally
Worse still, people are
taking matters into their own hands.
Self-management options such as
nutritional supplements and avoiding
activity due to pain were found to be
almost twice as popular as evidence-based
treatments, like education, exercise or
Although exercise is a core treatment for
, the report
reveals that one in five respondents
believe that exercise will make the pain
worse or won’t make any difference to
the most common barrier to exercise
described by respondents was joint pain.
As healthcare professionals, pharmacists
should urge patients with osteoarthritis
to do away with plans for hibernation
Uptake of recommended treatments can
also be improved with only 45 per cent
of respondents being satisfied with
their current pain management
Patients can often find that
paracetamol is not enough to cope
with pain, particularly on flare-up days.
For uncomplicated knee osteoarthritis,
international treatment guidelines
recommend topical non-steroidal
anti-inflammatory drugs (NSAIDs)
as a first-line treatment consideration,
along with paracetamol.
osteoarthritis, the European League
Against Rheumatism (EULAR) guidelines
recommend topical NSAIDs in initial
Pharmacists are able to help reduce
the impact osteoarthritis has on a
patient’s lifestyle, as well as providing
up-to date advice on pain management
recommendations. The core issue for
pharmacists is to guide and educate
these patients to seek advice on
osteoarthritis symptoms early on and
tailor management options to suit their
1. Marra CA, Cibere J, Tsuyuki RT et al. Improving
osteoarthritis detection in the community: pharmacist
identification of new, diagnostically confirmed
osteoarthritis. Arthritis Rheum 2007; 57: 1238–44 .
2. Voltaren® Osteo Gel Keep Moving Report, market research
conducted by Ipsos for Novartis Consumer Health, July
3. Law AV, Shapiro K. Impact of a community pharmacist-
directed clinic in improving screening and awareness of
osteoporosis. J Eval Clin Pract 2005;11:247–55 .
4. Marra CA, Cibere J, Grubisic M et al. Pharmacist-initiated
intervention trial in osteoarthritis: a multidisciplinary
intervention for knee osteoarthritis. Arthritis Care Res
(Hoboken) 2012; 64: 1837–45.
5. Osteoarthritis: management principles [revised 2010
Oct]. In: eTG complete [Internet]. Melbourne: Therapeutic
Guidelines Limited; 2015 Mar.
6. McAlindon T, Bannuru R, Sullivan M, et al. OARSI guidelines
for the non-surgical management of knee osteoarthritis.
Osteoarthr Cartil 2014; 22: 363-88 .
7. Jordan K, Arden N, Doherty M et al. EULAR
Recommendations 2003: an evidence based approach to
the management of knee osteoarthritis: Report of a Task
Force of the Standing Committee for International Clinical
Studies Including Therapeutic Trials (ESCISIT ). Ann Rheum
Dis 2003; 62: 1145-55 .
8. American Academy of Orthopaedic Surgeons. Treatment
of osteoarthritis of the knee: evidence-based guideline,
2nd edition. Rosemont: AAOS; 2013
9. Zhang W, Doherty M, Leeb B et al. EULAR evidence
based recommendations for the management of hand
osteoarthritis: report of a Task Force of the EULAR Standing
Committee for International Clinical Studies Including
Therapeutics (ESCISIT ). Ann Rheum Dis 2007; 66: 377-88.
osteoarthritis learn to
‘just put up with the pain’
Novartis Consumer Health – a GSK company
Links Archive Australian Pharmacist June 2015 Australian Pharmacist August 2015 Navigation Previous Page Next Page